Even in difficult market conditions,, the Heidenheim-based health care company sees itself well positioned for the current year to successfully continue its growth strategy. Ongoing high raw material prices, the Euro crisis and the high debts of some EU countries have a burdening impact on the performance of the HARTMANN GROUP. The company also continues to expect earnings effects from higher expenses associated with an investment program and costs resulting from solving quality problems in some sterile products.
Overall, HARTMANN expects slight growth in sales revenues across the four business segments for fiscal year 2012. The company is expecting the operating result to remain at the level of the record year of 2011. Due to the extraordinary, the company will see a decline in its earnings compared to the previous year.